Gastroenterology at Ruijin Hospital Shanghai | CMCS

Expert Digestive Care at One of China's Premier Academic Medical Centers

The Department of Gastroenterology at Ruijin Hospital — affiliated with Shanghai Jiao Tong University School of Medicine — is one of China's most distinguished centers for the diagnosis and management of digestive diseases. With expertise spanning inflammatory bowel disease, gastrointestinal oncology, advanced endoscopy, liver disease, and functional GI disorders, the department provides comprehensive, evidence-based care for patients with conditions ranging from common digestive complaints to complex, rare, and treatment-refractory disease.

For international patients seeking specialist gastroenterology care in Shanghai, Ruijin Hospital's department offers a combination of clinical excellence, advanced endoscopic capability, and research leadership that is among the finest in China. China Medical Concierge Shanghai (CMCS) provides seamless end-to-end coordination for international patients throughout their care journey.

About the Department

Ruijin Hospital's gastroenterology department is a national key clinical specialty operating a comprehensive GI unit that includes dedicated inpatient wards, a high-volume endoscopy center, a dedicated IBD clinic, a liver disease service, a GI oncology multidisciplinary team (MDT), and a functional GI disorders clinic. The department's endoscopy center is one of the busiest in Shanghai, performing tens of thousands of procedures annually including advanced therapeutic endoscopy.

Faculty members publish regularly in leading GI journals including Gastroenterology, Gut, Journal of Hepatology, Inflammatory Bowel Diseases, and Endoscopy.

Conditions Treated

• Inflammatory Bowel Disease (IBD) — Crohn's disease and ulcerative colitis; full range of biologic therapies (anti-TNF, anti-integrin, anti-IL-12/23, JAK inhibitors); treat-to-target strategies with mucosal healing endpoints
• Colorectal Cancer & Polyps — Colonoscopic screening, polypectomy, EMR, and ESD for early colorectal neoplasia; MDT management for advanced colorectal cancer
• Gastric Cancer & Precancerous Lesions — Early gastric cancer detection, ESD, and surveillance of atrophic gastritis and intestinal metaplasia
• Esophageal Cancer & Barrett's Esophagus — Endoscopic diagnosis, staging, and ESD for early esophageal neoplasia
• Gastroesophageal Reflux Disease (GERD) — Medical management and endoscopic anti-reflux procedures
• Peptic Ulcer Disease & H. pylori — H. pylori eradication, ulcer management, and endoscopic hemostasis for GI bleeding
• Chronic Hepatitis B & C — Antiviral therapy; liver fibrosis assessment; cirrhosis management
• Non-Alcoholic Fatty Liver Disease (NAFLD/NASH) — Metabolic management in collaboration with endocrinology
• Liver Cirrhosis & Portal Hypertension — Variceal management, ascites, and hepatic encephalopathy
• Pancreatitis — Acute and chronic pancreatitis; endoscopic management of pancreatic duct complications
• Pancreatic Cysts & Tumors — EUS-guided diagnosis and staging
• Biliary Tract Disease — ERCP for choledocholithiasis, biliary strictures, and cholangitis
• Irritable Bowel Syndrome & Functional GI Disorders — Evidence-based management of IBS, functional dyspepsia, and chronic constipation
• Eosinophilic Esophagitis & Esophageal Motility Disorders — Including achalasia treated with POEM
• GI Bleeding — Urgent endoscopic evaluation and hemostasis for upper and lower GI hemorrhage

Leading Specialists

Prof. Yuan Yaozong (袁耀宗) — Former Director, Gastroenterology

Prof. Yuan Yaozong is one of China's most distinguished gastroenterologists and a nationally recognized authority in inflammatory bowel disease, gastrointestinal oncology, and advanced endoscopy. As former Director of the Department of Gastroenterology at Ruijin Hospital, Prof. Yuan built the department into one of China's premier GI centers over decades of clinical leadership. He has been a key contributor to national IBD guidelines and has extensive experience in the management of complex Crohn's disease and ulcerative colitis, including patients who have failed multiple lines of biologic therapy. His endoscopy program has been at the forefront of ESD adoption in China, and he has trained numerous gastroenterologists in advanced endoscopic techniques.

Prof. Wang Xingpeng (王兴鹏) — Gastroenterology & Pancreatic Disease

Prof. Wang Xingpeng is a leading gastroenterologist with particular expertise in pancreatic disease, biliary disorders, and advanced endoscopy. His clinical program provides expert management for patients with acute and chronic pancreatitis, pancreatic cysts, and biliary tract disease, with a particular strength in endoscopic management including ERCP, EUS-guided procedures, and endoscopic drainage of pancreatic complications. Prof. Wang has published extensively on pancreatic disease and has contributed to national guidelines for pancreatitis management in China.

IBD Program: Comprehensive Biologic Therapy

Ruijin Hospital's IBD program is one of the most comprehensive in Shanghai, offering the full range of approved biologic and targeted therapies for Crohn's disease and ulcerative colitis:

Biologic Therapies

• Anti-TNF Agents — Infliximab, adalimumab, certolizumab (Crohn's), golimumab (UC); therapeutic drug monitoring and dose optimization
• Anti-Integrin Therapy — Vedolizumab for both Crohn's disease and ulcerative colitis; gut-selective mechanism with favorable safety profile
• Anti-IL-12/23 Therapy — Ustekinumab for Crohn's disease and ulcerative colitis
• Anti-IL-23 Therapy — Risankizumab for Crohn's disease; mirikizumab for ulcerative colitis

Small Molecule Therapies

• JAK Inhibitors — Tofacitinib, upadacitinib, and filgotinib for ulcerative colitis; upadacitinib for Crohn's disease
• S1P Receptor Modulators — Ozanimod and etrasimod for ulcerative colitis

Treat-to-Target Strategy

Ruijin's IBD team follows a rigorous treat-to-target approach, with treatment goals including clinical remission, endoscopic mucosal healing, and normalization of inflammatory biomarkers (CRP, fecal calprotectin). Regular endoscopic assessment and therapeutic drug monitoring guide treatment optimization, ensuring that patients achieve and maintain deep remission.

Advanced Endoscopy Program

Ruijin's endoscopy center offers the full range of advanced diagnostic and therapeutic endoscopic procedures:

Diagnostic Endoscopy

• High-Definition Upper GI Endoscopy — With chromoendoscopy and NBI for enhanced lesion detection
• Colonoscopy — AI-assisted polyp detection for enhanced adenoma detection rates
• Endoscopic Ultrasound (EUS) — High-resolution imaging and FNA/FNB for subepithelial lesions, pancreatic masses, and lymph node staging
• Capsule Endoscopy — Small bowel visualization for obscure GI bleeding and Crohn's disease
• Double-Balloon Enteroscopy — Deep small bowel examination and therapy

Therapeutic Endoscopy

• Endoscopic Submucosal Dissection (ESD) — En bloc resection of early GI cancers and large flat polyps
• Endoscopic Mucosal Resection (EMR) — Resection of smaller polyps and superficial mucosal lesions
• Peroral Endoscopic Myotomy (POEM) — Minimally invasive treatment for achalasia
• ERCP — Bile duct stone removal, biliary stenting, and pancreatic duct interventions
• EUS-Guided Drainage — Drainage of pancreatic pseudocysts and walled-off necrosis
• Endoscopic Hemostasis — Injection, clipping, and thermal therapy for acute GI bleeding

Why International Patients Choose Ruijin Gastroenterology

• IBD Excellence — Full range of biologic and small molecule therapies with treat-to-target approach and therapeutic drug monitoring
• Advanced Endoscopy — High-volume ESD, POEM, EUS, and ERCP program with experienced therapeutic endoscopists
• GI Oncology MDT — Multidisciplinary tumor board for personalized GI cancer treatment planning
• Pancreatic Disease Expertise — Specialist management of complex pancreatitis and pancreatic cysts with advanced endoscopic capabilities
• Academic Excellence — Shanghai Jiao Tong University affiliation with strong research culture and international collaborations
• Cost-Effectiveness — World-class GI care at significantly lower cost than equivalent treatment in Western countries

The CMCS Patient Journey

1. Initial Inquiry — Share your GI history, endoscopy reports, pathology results, imaging, and current medications with CMCS.
2. Medical Record Preparation — We translate and organize your records for specialist pre-consultation review.
3. Specialist Matching — We identify the most appropriate gastroenterologist based on your condition — IBD, GI oncology, liver disease, or pancreatic disease.
4. Priority Scheduling — We secure a consultation with minimal waiting time.
5. Travel & Logistics — Assistance with visa invitation letters, accommodation near Ruijin Hospital, and Shanghai airport transfers.
6. On-Site Concierge — Bilingual coordinators accompany you throughout your hospital visits, managing registration, translation, and communication.
7. Procedure Coordination — Full coordination of endoscopy, ERCP, EUS, biopsy, and other required procedures.
8. Post-Treatment Follow-Up — Pathology report translation, treatment plan interpretation, and remote follow-up coordination after you return home.

Book a Consultation

If you are seeking expert gastroenterology care in Shanghai — whether for IBD, GI cancer, liver disease, pancreatic disease, or advanced endoscopy — CMCS can arrange a specialist consultation with Ruijin Hospital's gastroenterology team.

📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com